ARTESE, Anna
 Distribuzione geografica
Continente #
NA - Nord America 2.538
AS - Asia 1.501
EU - Europa 1.091
SA - Sud America 317
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 5.486
Nazione #
US - Stati Uniti d'America 2.446
SG - Singapore 594
CN - Cina 480
IT - Italia 474
BR - Brasile 251
IN - India 200
DE - Germania 181
VN - Vietnam 118
GB - Regno Unito 111
FI - Finlandia 93
SE - Svezia 82
CA - Canada 70
UA - Ucraina 51
AR - Argentina 32
HK - Hong Kong 24
EE - Estonia 20
ES - Italia 17
ID - Indonesia 14
JP - Giappone 14
ZA - Sudafrica 12
MX - Messico 11
NL - Olanda 11
FR - Francia 10
IQ - Iraq 10
BD - Bangladesh 9
EC - Ecuador 9
CZ - Repubblica Ceca 8
CO - Colombia 7
TR - Turchia 7
EU - Europa 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EG - Egitto 4
IR - Iran 4
MA - Marocco 4
PE - Perù 4
PL - Polonia 4
AL - Albania 3
CL - Cile 3
DZ - Algeria 3
LT - Lituania 3
PY - Paraguay 3
TW - Taiwan 3
AF - Afghanistan, Repubblica islamica di 2
AT - Austria 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
MN - Mongolia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
PT - Portogallo 2
RO - Romania 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
PS - Palestinian Territory 1
PW - Palau 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 5.486
Città #
Dallas 566
Chandler 336
Singapore 218
Santa Clara 160
Munich 153
Hefei 145
Bengaluru 144
Ashburn 143
Milan 130
Lawrence 124
Princeton 124
London 75
Wilmington 70
Beijing 62
Chicago 58
Helsinki 55
Ottawa 54
Ho Chi Minh City 48
Des Moines 46
Catanzaro 40
Los Angeles 29
Turku 28
Shanghai 26
Hanoi 24
São Paulo 24
Hong Kong 23
Washington 19
Boardman 16
Brooklyn 16
Guangzhou 15
Pune 15
San Francisco 15
New York 13
Rome 13
Shenzhen 11
Tokyo 11
Curitiba 10
Redmond 10
Norwalk 9
Casoria 8
Chennai 8
Johannesburg 8
Olomouc 8
Phoenix 8
Rio de Janeiro 8
San Nicola Manfredi 8
Brasília 7
Cagliari 7
Naples 7
Boston 6
Crotone 6
Hanover 6
Jyväskylä 6
Messina 6
Seattle 6
Weihai 6
Biên Hòa 5
Catania 5
Charlotte 5
Columbus 5
Denver 5
Guayaquil 5
Haiphong 5
Luni 5
Montevideo 5
Montreal 5
Palermo 5
Redwood City 5
San Mateo 5
The Dalles 5
Toronto 5
Wuhan 5
Anagni 4
Atlanta 4
Aversa 4
Council Bluffs 4
Dongyang 4
Heidesheim 4
Jiaxing 4
Lima 4
Porto Alegre 4
Santander 4
Siena 4
Stockholm 4
Thái Bình 4
Treviso 4
Vallefiorita 4
Afragola 3
Amsterdam 3
Avola 3
Bogotá 3
Bonn 3
Castrovillari 3
Cosenza 3
Erbil 3
Ferrara 3
Fortaleza 3
Fuzhou 3
Giulianova 3
Guarulhos 3
Totale 3.376
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 192
A Candidate multi-targeting approach to block the CD98hc oncoprotein 89
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 82
GBPM: applicazione al docking molecolare 81
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 72
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 70
A Computational pathway toward the rational design of azinomycin analogues 68
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations 66
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 66
Chemioterapici antifungini 65
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 64
Back Cover: Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement (ChemMedChem 16/2016) 63
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 63
Identification and Characterization of New DNA G-Quadruplex Binders Selected by a Combination of Ligand and Structure-Based Virtual Screening Approaches 60
Molecular recognition of a carboxy pyridostatin towards G-quadruplex structures: why does it prefer RNA? 59
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 59
A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences 58
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 58
Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors 57
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 54
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 54
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures 53
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 53
Characterization of the role of two additional HIV-1 reverse transcriptase mutations in the regulation of NNRTI resistance 52
Computer-based techniques for lead identification and optimization II: Advanced search methods 52
CoMFA studies of non covalent monoamine oxidase inhibitors 51
Comparison of molecular dynamics simulations carried out on wild type and mutants of HIV-1 reverse transcriptase 50
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 50
Identification and Structural Characterization of Novel Genetic Elements in HIV-1 - V3 Loop Regulating Co-Receptor Usage 49
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 49
Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach 49
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 48
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 48
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders 48
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 48
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 48
Characterization and structural analysis of HIV-1 integrase conservation 48
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 48
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 48
From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds 46
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures 46
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 45
GBPM analysis of HIV-1 reverse transcriptase–DNA crystallographic complexes focused on the enzyme conserved regions of HAART-treated patients 45
Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics 45
Natural products extracted from fungal species as new potential anti-cancer drugs: A structure-based drug repurposing approach targeting HDAC7 45
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 44
Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients 43
Computer-based techniques for lead identification and optimization i: Basics 43
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 42
Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors 42
Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620 41
Computational analysis of HIV-1 reverse transcriptase complexes 41
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 41
Indagine statistica sulla diffusione nell’Industria farmaceutica italiana di tecnologie computazionali avanzate orientate alla progettazione di nuovi farmaci 40
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors 40
Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders 40
Identification of new G-quadruplex binders by combined virtual screening approaches. 40
Dinamica molecolare di complessi della proteasi di HIV-1: influenza di mutazioni associate a resistenza sulla ricognizione molecolare 40
Composti per il G-quadruplex a struttura naftilimmidica 39
Studi computazionali su modelli di Trascrittasi Inversa del virus HIV 39
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 38
Metodi computazionali e nutraceutica 38
Progettazione razionale di agenti bisalchilanti del DNA analoghi delle azinomicine 38
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods 38
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase 37
Conformation and stability of intramolecular telomeric g-quadruplexes: sequence effects in the loops 37
Conformational analysis of bioactive conformations in the drug discovery process 37
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 36
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 36
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 35
Computational study on DNA G-quadruplex binding compounds 35
Design and Synthesis of a (N-Alkylaminoalkyl-Substituted) Arylalkenylamide Drug Discovery Library 35
Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery? 35
An overview on olfaction in the biological, analytical, computational, and machine learning fields 35
High-throughput lipophilicity screening of opioid-like analgesics: validation of computational methods by means of RP-HPLC analysis 34
Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold 34
Computational approaches for discovery and optimization of G-quadruplex binders 34
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 33
Docking e virtual screening su composti naturali: esempi su quercitina e cucurbitacina 33
Structure-Based Virtual Screening of Novel Natural Alkaloid Derivatives as Potential Binders of h-telo and c-myc DNA G-Quadruplex Conformations 33
Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies 33
Docking comparativo nello sviluppo di ligandi per il DNA G-quadruplex 33
Hit identification and biological evaluation of anticancer pyrazolo-pyrimidines endowed with anti-inflammatory activity 32
Dependence of DNA sequence selectivity and cell cytotoxicity on azinomycin A and B epoxyamide stereochemistry 32
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir containing regimens 32
Molecular interaction fields in drug discovery: recent advances and future perspectives 32
Progettazione razionale e sintesi di prodotti di semplificazione molecolare delle azinomicine 32
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance 32
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T). 32
Computer-based techniques for lead identification and optimization I: Basics 31
Hit identification of novel DNA-quadruplex ligands 31
Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral treated HIV-1 infected patients, all naïve to integrase inhibitors 31
Rational drug design of DNA cross-linking agents 31
New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors 31
Structure-based pharmacophore modeling of DNA G-Quadruplex ligand-complexes. 31
Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance 30
Molecular Recognition Of Dna G-Quadruplex Ligands By Different Docking Methods 30
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 30
Docking studies of Lopinavir, Atazanavir and Darunavir binding modes to HIV-1 protease mutants 29
STATISTICAL ANALISYS OF DRUG DESIGN COMPUTATIONAL TECNIQUES AMONG THE RESEARCH GROUPS IN ITALY 29
Totale 4.614
Categoria #
all - tutte 57.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021115 0 0 0 0 27 20 23 4 16 13 8 4
2021/2022331 4 2 10 64 23 6 14 80 22 33 69 4
2022/20231.003 253 48 46 72 111 72 9 70 156 59 83 24
2023/2024513 72 57 46 31 33 152 12 45 4 21 16 24
2024/20251.709 204 143 65 59 117 199 92 66 221 119 155 269
2025/20261.706 172 358 650 488 38 0 0 0 0 0 0 0
Totale 5.578